A detailed history of Bison Wealth, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bison Wealth, LLC holds 7,629 shares of BMY stock, worth $448,432. This represents 0.07% of its overall portfolio holdings.

Number of Shares
7,629
Previous 8,052 5.25%
Holding current value
$448,432
Previous $334,000 17.96%
% of portfolio
0.07%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$39.66 - $51.75 $16,776 - $21,890
-423 Reduced 5.25%
7,629 $394,000
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $14,537 - $16,483
303 Added 3.91%
8,052 $436,000
Q4 2023

Jan 30, 2024

BUY
$48.48 - $57.85 $66,950 - $79,890
1,381 Added 21.69%
7,749 $397,000
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $66,457 - $74,310
-1,148 Reduced 15.27%
6,368 $369,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $197,883 - $219,718
3,106 Added 70.43%
7,516 $480,000
Q4 2022

Feb 10, 2023

SELL
$68.48 - $81.09 $25,748 - $30,489
-376 Reduced 7.86%
4,410 $317,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $44 - $26,048
339 Added 7.62%
4,786 $340,000
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $2,832 - $3,119
-39 Reduced 0.87%
4,447 $342,000
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $10,267 - $12,311
-167 Reduced 3.59%
4,486 $328,000
Q4 2021

Feb 02, 2022

BUY
$53.63 - $62.52 $11,476 - $13,379
214 Added 4.82%
4,653 $290,000
Q3 2021

Nov 03, 2021

SELL
$59.17 - $69.31 $15,857 - $18,575
-268 Reduced 5.69%
4,439 $263,000
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $26,435 - $28,788
427 Added 9.98%
4,707 $315,000
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $102,658 - $115,460
-1,730 Reduced 28.79%
4,280 $270,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $7,332 - $8,309
127 Added 2.16%
6,010 $373,000
Q3 2020

Oct 16, 2020

SELL
$57.43 - $63.64 $15,678 - $17,373
-273 Reduced 4.43%
5,883 $355,000
Q2 2020

Aug 03, 2020

SELL
$54.82 - $64.09 $251,294 - $293,788
-4,584 Reduced 42.68%
6,156 $362,000
Q1 2020

May 04, 2020

SELL
$46.4 - $67.43 $859,049 - $1.25 Million
-18,514 Reduced 63.29%
10,740 $599,000
Q4 2019

Feb 05, 2020

SELL
$49.21 - $64.19 $54,475 - $71,058
-1,107 Reduced 3.65%
29,254 $1.88 Million
Q3 2019

Nov 04, 2019

SELL
$42.77 - $50.71 $727 - $862
-17 Reduced 0.06%
30,361 $1.54 Million
Q2 2019

Aug 05, 2019

BUY
$44.62 - $49.34 $928,408 - $1.03 Million
20,807 Added 217.4%
30,378 $1.38 Million
Q1 2019

May 09, 2019

BUY
$45.12 - $53.8 $95,925 - $114,378
2,126 Added 28.56%
9,571 $457,000
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $19,504 - $25,292
-400 Reduced 5.1%
7,445 $387,000
Q3 2018

Nov 09, 2018

SELL
$55.19 - $62.25 $1,324 - $1,494
-24 Reduced 0.3%
7,845 $487,000
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $2,172 - $2,708
43 Added 0.55%
7,869 $435,000
Q1 2018

May 08, 2018

SELL
$59.92 - $68.98 $2,576 - $2,966
-43 Reduced 0.55%
7,826 $495,000
Q4 2017

Jan 29, 2018

SELL
$59.94 - $65.35 $30,269 - $33,001
-505 Reduced 6.03%
7,869 $482,000
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $462,496 - $533,758
8,374
8,374 $534,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bison Wealth, LLC Portfolio

Follow Bison Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bison Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bison Wealth, LLC with notifications on news.